Wilkinson.
Pharmac is often criticised for not funding enough new medicines and for being too slow to determine which ones it will fund. However, being slow and focused is not proof of being too slow or too focused.
Additional funding for healthcare welcomed but structural issues remain
Additional funding for healthcare welcomed but structural issues remain
Additional funding for primary healthcare is a good thing, even where it is a mix of previous funding decisions, reallocation of other health funding read...